333
Participants
Start Date
July 24, 2017
Primary Completion Date
April 3, 2020
Study Completion Date
September 28, 2022
Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody
Atezolizumab was administered as per schedule described in respective arm.
Placebo
Placebo matched to atezolizumab was administered as per schedule described in respective arm.
Nab-paclitaxel
Nab-paclitaxel was administered as per schedule described in the arms.
Doxorubicin
Doxorubicin was administered as per schedule described in the arms.
Cyclophosphamide
Cyclophosphamide was administered as per schedule described in the arms.
Filgrastim
Filgrastim was administered according to local prescribing information as determined by the Investigator for 4 doses after completion of initial 12 weeks.
Pegfilgrastim
Pegfilgrastim was administered according to local prescribing information as determined by the Investigator for 4 doses after completion of initial 12 weeks.
Mackay Memorial Hospital; Dept of Surgery, Taipei
Chang Gung Medical Foundation Linkou Branch, Taoyuan
Cliniques Universitaires St-Luc, Brussels
Sint Augustinus Wilrijk, Wilrijk
UZ Leuven Gasthuisberg, Leuven
Monash Medical Centre, Clayton
Clinique Ste-Elisabeth, Namur
Fiona Stanley Hospital; FSH Cancer Centre Clinical Trials Unit, Bull Creek
Memorial Sloan Kettering Cancer Center, New York
Praxisklinik Krebsheilkunde für Frauen / Brustzentrum (Dres. Kittel/Klare), Berlin
National Cancer Center, Goyang-si
Ambulantes Tumorzentrum Spandau; Dres. Benno Mohr und Uwe Peters, Berlin
Irccs Ospedale San Raffaele, Milan
Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem, Hamburg
Ospedale San Gerardo, Monza
Mercy Medical Center, Baltimore
Medizinisches Versorgungszentrum am Klinikum Oldenburg GmbH, Oldenburg
Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital, Carrollton
Diakovere Henriettenstift, Frauenklinik, Hanover
Onkologische Schwerpunktpraxis Bielefeld, Bielefeld
Azienda ULSS 8 Berica; Oncologia Medica - Ospedlae di Vicenza, Vicenza
Tennessee Oncology, Nashville
Vanderbilt Breast Center at One Hundred Oaks, Nashville
Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street, Chattanooga
Luisenkrankenhaus GmbH & Co. KG., Brustzentrum, Düsseldorf
Hospital Universitario Virgen del Rocio; Servicio de Oncologia, Seville
Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum, Gelsenkirchen
Universitätsklinikum Münster; Klinik für Frauenheilkunde und Geburtshilfe, Münster
Hochwaldkrankenhaus, Bad Nauheim
Dres. Andreas Köhler und Roswitha Fuchs, Langen
HCA Midwest Division, Kansas City
The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth
Klinik & Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt, München
Stanford University Medical Center, Palo Alto
Cancer Care Northwest, Spokane
Norwalk Hospital, Norwalk
The Valley Hospital; Valley Medical Group, Paramus
Santa Casa de Misericordia de Salvador, Salvador
Hospital Araujo Jorge; Departamento de Ginecologia E Mama, Goiânia
CETUS Hospital Dia Oncologia, Uberaba
Iop Instituto de Oncologia Do Parana, Curitiba
Clinicas Oncologicas Integradas - COI, Rio de Janeiro
Hospital Sao Lucas - PUCRS, Porto Alegre
Hospital Nossa Senhora da Conceicao, Porto Alegre
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, São Paulo
Jewish General Hospital, Montreal
Hopital Sacre-Coeur Research Centre, Montreal
Hopital du Saint Sacrement, Québec
St. Elisabeth-Krankenhaus, Senologie/Brustzentrum, Leipzig
Aichi Cancer Center Hospital, Aichi
National Hospital Organization Shikoku Cancer Center, Ehime
Fukushima Medical University Hospital, Fukushima
Hiroshima City Hiroshima Citizens Hospital; Breast Surgery, Hiroshima
Kanagawa Cancer Center, Kanagawa
Tokai University Hospital, Kanagawa
National Hospital Organization Osaka National Hospital; Breast Surgery, Osaka
St. Luke's Internat. Hospital, Breast Surgical Oncology, Tokyo
The Cancer Inst. Hosp. of JFCR; Breast Oncology Center, Tokyo
Narodowy Inst.Onkologii im.Sklodowskiej-Curie Panstw.Inst.Bad; Klinika Nowtw.Piersi i Chir.Rekonstr, Warsaw
Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii; Oddz. Onkologii Klin. i Chemioterapii, Wroc?aw
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
VETERANS GENERAL HOSPITAL; Department of General Surgery, Taipei
Leicester Royal Infirmary, Leicester
Barts & London School of Med; Medical Oncology, London
Freeman Hospital, Newcastle upon Tyne
Hoffmann-La Roche
INDUSTRY